Mallinckrodt Plc (NYSE:MNK)

128.81
Delayed Data
As of May 21
 -0.23 / -0.18%
Today’s Change
67.18
Today|||52-Week Range
134.26
+30.07%
Year-to-Date

Today’s Trading

Previous close129.04
Today’s open128.80
Day’s range127.62 - 129.28
Volume640,892
Average volume (3 months)1,296,102
Market cap$15.1B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-582.35%
Earnings growth (this year)+48.95%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+15.24%
P/E ratioNM
Price/Sales2.30
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
HSPHospira Inc+0.18+0.20%
ENDPEndo International P...-0.65-0.76%
JAZZJazz Pharmaceuticals...-0.06-0.03%
INCYIncyte Corp-1.26-1.15%
Data as of 05/21/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)$1.80
Annual revenue (last year)$2.5B
Annual profit (last year)-$319.3M
Net profit margin-12.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers